The information contained on this website is intended exclusively for healthcare professionals qualified to prescribe, dispense or recommend medicinal products.

Close-up of a blue-gloved hand holding an vial of injectable medicine at the Ferrer production plant.

Business

PRODUCTS

We specialize in own-brand prescription drugs, mainly for hospital use

As a pharmaceutical company, we contribute to health, a fundamental human right and an essential condition for exercising all other individual and collective rights. A necessary foundation for social justice.

 

After more than 65 years of activity, we have significant experience and specialization in the areas of neurology, cardiovascular intensive care, Cardiometabolism and pain management.

 

With the goal of providing meaningful and distinctive value to people suffering from severe conditions, Ferrer is increasingly focusing on two therapeutic areas: pulmonary vascular and interstitial lung diseases and rare neurological diseases.

18 results found

  • Product

    Acalka

    Product Type

    Medicinal product

    Active ingredient

    Potassium Citrate prolonged-release tablet

    Therapeutic area

    Urology

  • Product

    Alzil

    Product Type

    Medicinal product

    Active ingredient

    Rosuvastatin

    Therapeutic area

    Cardiovascular

  • Product

    Alzil Plus

    Product Type

    Medicinal product

    Active ingredient

    Ezetimibe + Rosuvastatin

    Therapeutic area

    Cardiovascular

  • Product

    Captor

    Product Type

    Medicinal product

    Active ingredient

    Tramadol + Paracetamol

    Therapeutic area

    Pain

  • Product

    Dermofix

    Product Type

    Medicinal product

    Active ingredient

    Sertaconazole

    Therapeutic area

    Dermatology

  • Product

    Eneas

    Product Type

    Medicinal product

    Active ingredient

    Enalapril + Nitrendipine

    Therapeutic area

    Cardiovascular

  • Product

    Haemonetics apheresis

    Product Type

    Medical device

    Active ingredient

    N/A

    Therapeutic area

    Hematology

  • Product

    Haemonetics autotransfusion

    Product Type

    Medical device

    Active ingredient

    N/A

    Therapeutic area

    Hematology

  • Product

    Hemovas

    Product Type

    Medicinal product

    Active ingredient

    Pentoxifylline

    Therapeutic area

    Cardiovascular

  • Product

    Kengrexal

    Product Type

    Medicinal product

    Active ingredient

    Cangrelor

    Therapeutic area

    Cardiovascular

  • Product

    Nubit

    Product Type

    Food supplement

    Active ingredient

    Uridine-5′-Disodium Monophosphate + Cytidine-5′-Disodium Monophosphate + Thiamine + Cyanocobalamin

    Therapeutic area

    Neurology

  • Product

    Omacor

    Product Type

    Medicinal product

    Active ingredient

    90% omega-3 fatty acid ethyl esters

    Therapeutic area

    Cardiovascular

  • Product

    Somazina

    Product Type

    Medicinal product

    Active ingredient

    CDP-Choline

    Therapeutic area

    Neurology

  • Product

    Tiorfan

    Product Type

    Medicinal product

    Active ingredient

    Racecadotrile

    Therapeutic area

    Gastroenterology

  • Product

    Trepostinilo Ferrer

    Product Type

    Medicinal product

    Active ingredient

    Trepostinil

    Therapeutic area

    Cardiovascular

  • Product

    Trinomia

    Product Type

    Medicinal product

    Active ingredient

    Atorvastatin + Ramipril + Acetylsalicylic Acid

    Therapeutic area

    Cardiovascular

  • Product

    Ub test

    Product Type

    Medicinal product (for diagnostic use)

    Active ingredient

    13-C UREA

    Therapeutic area

    Gastroenterology

  • Product

    Zalain

    Product Type

    Medicinal product

    Active ingredient

    Sertaconazole

    Therapeutic area

    Dermatology

HEALTHCARE PROFESSIONALS

At Ferrer we ensure that the medical community is reliably informed about the use and administration of our medicinal products.

Last updated: July 2026